Annual EBITDA
-$40.27 M
+$4.86 M+10.77%
31 December 2023
Summary:
Eliem Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$40.27 million, with the most recent change of +$4.86 million (+10.77%) on 31 December 2023. During the last 3 years, it has fallen by -$4.60 million (-12.90%).ELYM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$11.78 M
+$44.59 M+79.10%
30 September 2024
Summary:
Eliem Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$11.78 million, with the most recent change of +$44.59 million (+79.10%) on 30 September 2024. Over the past year, it has dropped by -$6.66 million (-130.07%).ELYM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$76.28 M
-$6.78 M-9.76%
30 September 2024
Summary:
Eliem Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$76.28 million, with the most recent change of -$6.78 million (-9.76%) on 30 September 2024. Over the past year, it has dropped by -$36.01 million (-89.41%).ELYM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELYM EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -130.1% | -89.4% |
| 3 y3 years | -12.9% | -10.1% | -113.8% |
| 5 y5 years | -757.6% | - | - |
ELYM EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +757.6% | +632.8% | +3809.9% |
Eliem Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.78 M(-79.1%) | -$76.28 M(+9.8%) |
| June 2024 | - | -$56.37 M(+1775.9%) | -$69.50 M(+250.3%) |
| Mar 2024 | - | -$3.00 M(-41.3%) | -$19.84 M(-50.7%) |
| Dec 2023 | -$40.27 M(-10.8%) | -$5.12 M(+2.4%) | -$40.27 M(-9.9%) |
| Sept 2023 | - | -$5.00 M(-25.5%) | -$44.71 M(-7.7%) |
| June 2023 | - | -$6.71 M(-71.4%) | -$48.45 M(-12.6%) |
| Mar 2023 | - | -$23.44 M(+145.3%) | -$55.44 M(+22.8%) |
| Dec 2022 | -$45.13 M | -$9.55 M(+9.2%) | -$45.13 M(-2.5%) |
| Sept 2022 | - | -$8.75 M(-36.2%) | -$46.28 M(-1.4%) |
| June 2022 | - | -$13.70 M(+4.3%) | -$46.92 M(+11.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.13 M(+22.7%) | -$41.92 M(+17.5%) |
| Dec 2021 | -$35.67 M(+203.2%) | -$10.70 M(+14.1%) | -$35.67 M(+15.4%) |
| Sept 2021 | - | -$9.38 M(+7.8%) | -$30.92 M(+29.9%) |
| June 2021 | - | -$8.71 M(+26.6%) | -$23.79 M(+42.5%) |
| Mar 2021 | - | -$6.88 M(+15.6%) | -$16.70 M(+41.9%) |
| Dec 2020 | -$11.77 M(+150.6%) | -$5.95 M(+163.3%) | -$11.77 M(+102.3%) |
| Sept 2020 | - | -$2.26 M(+40.5%) | -$5.82 M(+63.5%) |
| June 2020 | - | -$1.61 M(-17.6%) | -$3.56 M(+82.4%) |
| Mar 2020 | - | -$1.95 M | -$1.95 M |
| Dec 2019 | -$4.70 M | - | - |
FAQ
- What is Eliem Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Eliem Therapeutics?
- What is Eliem Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Eliem Therapeutics?
- What is Eliem Therapeutics quarterly EBITDA year-on-year change?
- What is Eliem Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Eliem Therapeutics?
- What is Eliem Therapeutics TTM EBITDA year-on-year change?
What is Eliem Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ELYM is -$40.27 M
What is the all time high annual EBITDA for Eliem Therapeutics?
Eliem Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$4.70 M
What is Eliem Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ELYM is -$11.78 M
What is the all time high quarterly EBITDA for Eliem Therapeutics?
Eliem Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.61 M
What is Eliem Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ELYM quarterly earnings before interest, taxes, depreciation & amortization has changed by -$6.66 M (-130.07%)
What is Eliem Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ELYM is -$76.28 M
What is the all time high TTM EBITDA for Eliem Therapeutics?
Eliem Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$1.95 M
What is Eliem Therapeutics TTM EBITDA year-on-year change?
Over the past year, ELYM TTM earnings before interest, taxes, depreciation & amortization has changed by -$36.01 M (-89.41%)